Serafini M, Cordaro C, Montanari E, Falcini F, Bucchi L
Romagna Cancer Registry, Luigi Pierantoni Hospital, Forlì, Italy.
Int J Epidemiol. 1999 Apr;28(2):196-203. doi: 10.1093/ije/28.2.196.
Treatment of cervical intraepithelial neoplasia grade 3 (CIN3) is one of the most unexplored issues of the monitoring of cervical cancer screening. We evaluated (1) the frequency of major patterns of diagnosis and treatment of CIN3 (ICD-O code 8070.2), (2) the determinants of hysterectomy as a first choice treatment, and (3) the determinants of invasive cervical squamous carcinoma (CSC) detection among CIN3 cases treated by hysterectomy.
A population-based, retrospective, descriptive (objective 1) and analytical (objectives 2 and 3) study was conducted by the Romagna Cancer Registry (Northern Italy). Included were 316 CIN3 patients (median age, 38.5 years; range, 21-80) registered between 1986 and 1993 and meeting one of the following eligibility criteria: histological diagnosis of CIN3 on biopsy with any subsequent treatment, histological diagnosis of CIN3 on conization, histological diagnosis of CIN3 on hysterectomy with previous negative/benign (< or = CIN2) biopsy or conization. Multivariate associations were evaluated by the multiple logistic regression.
Of 316 patients, 264 (84%) were first diagnosed on biopsy, 39 (12%) on conization, and 13 (4%) on hysterectomy. Among the 264 patients diagnosed on biopsy, the first choice treatment was local destructive therapy for 16 (6%), conization for 155 (59%) and hysterectomy for 93 (35%). Age was the strongest uni/multivariate predictor of hysterectomy (the most frequent first choice treatment >40 years) followed by adequacy of biopsy (inverse association) and place of treatment (decreased probability for patients treated outside the area and in the private sector). Among the 93 CIN3 patients undergoing hysterectomy, 23 (25%) had a CSC diagnosed. Multivariate analysis showed that the probability of CSC detection was related to adequacy of biopsy (inverse association), year of registration, and biopsy-to-treatment interval (inverse association).
Hysterectomy was a common treatment for patients with CIN3 on biopsy. Only in a minority of hysterectomized patients was a CSC diagnosed. Difficulties and inefficiencies in the biopsy and assessment procedure were found to be important factors in the management and outcome of CIN3 patients.
宫颈上皮内瘤变3级(CIN3)的治疗是宫颈癌筛查监测中最未被充分探索的问题之一。我们评估了(1)CIN3(ICD-O编码8070.2)的主要诊断和治疗模式的频率,(2)子宫切除术作为首选治疗方法的决定因素,以及(3)在接受子宫切除术治疗的CIN3病例中浸润性宫颈鳞状细胞癌(CSC)检测的决定因素。
由罗马涅癌症登记处(意大利北部)进行了一项基于人群的回顾性描述性(目标1)和分析性(目标2和3)研究。纳入了1986年至1993年间登记的316例CIN3患者(中位年龄38.5岁;范围21 - 80岁),且符合以下资格标准之一:活检组织学诊断为CIN3且有任何后续治疗、锥切组织学诊断为CIN3、子宫切除组织学诊断为CIN3且之前活检或锥切为阴性/良性(≤CIN2)。通过多元逻辑回归评估多变量关联。
316例患者中,264例(84%)首次诊断于活检,39例(12%)于锥切,13例(4%)于子宫切除。在264例经活检诊断的患者中,首选治疗为局部破坏性治疗者16例(6%),锥切者155例(59%),子宫切除者93例(35%)。年龄是子宫切除术最强的单变量/多变量预测因素(最常见的首选治疗是年龄>40岁者),其次是活检充分性(负相关)和治疗地点(在该地区以外和私立部门接受治疗的患者概率降低)。在93例接受子宫切除术的CIN3患者中,23例(25%)诊断为CSC。多变量分析显示,CSC检测的概率与活检充分性(负相关)、登记年份和活检至治疗间隔(负相关)有关。
子宫切除术是活检诊断为CIN3患者的常见治疗方法。仅少数接受子宫切除术的患者诊断为CSC。活检和评估程序中的困难和低效被发现是CIN3患者管理和结局的重要因素。